The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells

1. Mendez, S.
2. Traslavina, R.
3. Hinchman, M.
4. Huang, L.
5. Green, P.
6. Cynamon, M.H.
7. Welch, J.T.